Gilead's acquisition of a stake in Ikena Oncology could potentially influence its strategic decisions and financial performance. However, the short-term impact on Gilead's stock price is uncertain as it depends on various factors including market perception of the investment and future plans for the stake.

Gilead's acquisition of a stake in Ikena Oncology could provide the latter with financial support and strategic guidance, which could potentially boost its growth prospects. This could have a positive impact on Ikena's stock price in the short term.